-
861
Grazoprevir and Elbasvir in Patients with Genotype 1 Hepatitis C Virus Infection: A Comprehensive Efficacy and Safety Analysis
Published 2017-01-01“…It is urgent for patients with hepatitis C virus (HCV) infection to find a safe, effective, and interferon-free regimen to optimize therapy. …”
Get full text
Article -
862
Achieving Hepatitis C Micro-Elimination in Chinese Injecting Drug Users: A Dynamic Network Modeling Study
Published 2024-12-01Subjects: “…Hepatitis C virus…”
Get full text
Article -
863
Knowledge, attitudes, practices, and vaccination coverage of medical students toward hepatitis B virus in North Sudan, 2023
Published 2025-01-01Subjects: Get full text
Article -
864
Treatment of end-stages of liver disease in outcome of persistent hepatitis C virus infection at deficiency of donor organs
Published 2011-03-01“…To study the role of serological markers of hepatitis B virus infection: antibodies to hepatitis B virus cor-antigen (anti-HВcor IgG) in progressing liver damage at patients with persistent hepatitis C virus infection.Material and methods. …”
Get full text
Article -
865
Noninvasive diagnosis of significant liver fibrosis in patients with chronic hepatitis B using nomogram and machine learning models
Published 2025-01-01Subjects: “…Chronic hepatitis B…”
Get full text
Article -
866
Hepatitis B Virus Reactivation in Patients With HBV-Related Advanced Hepatocellular Carcinoma Undergoing Lenvatinib and Camrelizumab Treatment
Published 2025-01-01“…Objective This study aimed to evaluate hepatitis B virus (HBV) reactivation and its effect on tumor response and survival outcomes in patients with HBV-related advanced hepatocellular carcinoma (HCC) undergoing lenvatinib plus camrelizumab treatment. …”
Get full text
Article -
867
Investigation of Antioxidant and Hepatoprotective Activity of Standardized Curcuma xanthorrhiza Rhizome in Carbon Tetrachloride-Induced Hepatic Damaged Rats
Published 2014-01-01“…Curcuma xanthorrhiza (CX) has been used for centuries in traditional system of medicine to treat several diseases such as hepatitis, liver complaints, and diabetes. It has been consumed as food supplement and “jamu” as a remedy for hepatitis. …”
Get full text
Article -
868
Nucleos(t)ide Analog Treatment Discontinuation in Chronic Hepatitis B Virus Infection: A Systematic Literature Review
Published 2025-01-01Subjects: Get full text
Article -
869
Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta Hepatitis
Published 2015-01-01“…Interferons are used for treatment of chronic hepatitis B. They can induce or exacerbate some skin disorders, such as lichen planus. …”
Get full text
Article -
870
NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation
Published 2018-01-01“…The aim of this study was to investigate the underlying antifibrosis mechanisms by which the BMSC inhibit activated hepatic stellate cells (HSCs) in vivo and in vitro. …”
Get full text
Article -
871
-
872
Hepatitis C Virus Clearance after Discontinuation of Pegylated Interferon Alpha-2a Monotherapy in a Child
Published 2012-01-01“…The present patient was a 4-year-old boy. His hepatitis C virus genotype was 2a, and his viral load was high (1400,000 U/mL). …”
Get full text
Article -
873
NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy
Published 2015-12-01Subjects: “…chronic hepatitis c…”
Get full text
Article -
874
Per1/Per2 double knockout transcriptome analysis reveals circadian regulation of hepatic lipid metabolism
Published 2023-09-01“…This study aimed to explore the effects of Per1/Per2 double knockout (DKO) on hepatic lipid metabolism in mice under HFD and HFD with docosahexaenoic acid (DHA) substitution. …”
Get full text
Article -
875
LIX1L aggravates MASH-HCC progression by reprogramming of hepatic metabolism and microenvironment via CD36
Published 2025-01-01“…Here, we identify LIX1L as a key integrative regulator linking lipid metabolism and inflammation, adipose tissue and hepatic microenvironment, which promotes MASH progression. …”
Get full text
Article -
876
Th1/Th2 Cells and Associated Cytokines in Acute Hepatitis E and Related Acute Liver Failure
Published 2020-01-01“…The involvement of cellular immunity in the development of hepatitis E virus (HEV) infection is rare. We aimed to study the roles of viral load and Th cell responses in acute hepatitis E (AHE) and HEV-related acute liver failure (HEV-ALF). …”
Get full text
Article -
877
Hepatoprotective Effects of Nasturtium Officinale and Allium Polyanthum Extracts on CCL4- Induced Hepatic Damage In Albino Rats
Published 2022-01-01Subjects: “…Carbon tetrachloride, CCl4 Hepatotoxicity, Hepatic damage, Rat, Nasturtium officinale and Allium polyanthum.…”
Get full text
Article -
878
Factors Associated with the Progression of Fibrosis on Liver Biopsy in Alaska Native and American Indian Persons with Chronic Hepatitis C
Published 2010-01-01“…BACKGROUND: Various factors influence the development and rate of fibrosis progression in chronic hepatitis C virus (HCV) infection.…”
Get full text
Article -
879
Pathomorphology of severe Grade 3-4 hepatic encephalopathy in decompensated cirrhosis patients with acute-on-chronic liver failure
Published 2024-06-01Subjects: “…hepatic encephalopathy…”
Get full text
Article -
880
The Increased Activity of Liver Lysosomal Lipase in Nonalcoholic Fatty Liver Disease Contributes to the Development of Hepatic Insulin Resistance
Published 2012-01-01“…Consequent overproduction of diacylglycerol may represent the causal link between HFD-induced hepatic TAG accumulation and hepatic insulin resistance via PKCε activation.…”
Get full text
Article